663
Views
4
CrossRef citations to date
0
Altmetric
Review

The role of sulfonylureas in the treatment of type 2 diabetes

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 387-403 | Received 24 Jul 2021, Accepted 25 Oct 2021, Published online: 10 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Brian Tomlinson, Yan-Hong Li & Paul Chan. (2022) Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 23:17, pages 1869-1877.
Read now

Articles from other publishers (3)

Lee‐Ling Lim, Eric S. H. Lau, Johnny T. K. Cheung, Siew Pheng Chan, Linong Ji, Soo Lim, Sirinart Sirinvaravong, A. G. Unnikrishnan, Andrea O. Y. Luk, Viviana Cortese, Alexandra Durocher & Juliana C. N. Chan. (2022) Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation ( JADE ) register . Diabetes, Obesity and Metabolism 25:1, pages 208-221.
Crossref
Faidon Magkos & Bettina Mittendorfer. (2022) Editorial: Type 2 diabetes therapeutics: weight loss and other strategies. Current Opinion in Clinical Nutrition & Metabolic Care 25:4, pages 256-259.
Crossref
Markus Wortmann, Rosa Klotz, Eva Kalkum, Susanne Dihlmann, Dittmar Böckler & Andreas S. Peters. (2022) Inflammasome Targeted Therapy as Novel Treatment Option for Aortic Aneurysms and Dissections: A Systematic Review of the Preclinical Evidence. Frontiers in Cardiovascular Medicine 8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.